
About Ledgent Pharma
Ledgent Pharma was a Healthcare company based in Kanpur (India) founded in 2020. It produces high-quality pharmaceutical products for the healthcare industry. It operates on a B2B model. Its Indian entity Ledgent Pharma Private Limited reported revenue of βΉ92.9 Lakh. The company is recorded as dissolved. Its focus areas include Pharmaceuticals, Drug Manufacturing and Product Development. Similar companies include Indoco Remedies, Concord Biotech and BDR Pharmaceuticals Internationals; 1 of its 3 listed similar companies has raised funding.
Company details
Ledgent Pharma operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and developing products. Produces high-quality pharmaceutical products for the healthcare industry. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
- Headquarters Kanpur, India
- Employees 1
- SectorsHealthcare
- Website ledgentpharma.com
- Legal Name Ledgent Pharma Private Limited
- Date of Incorporation 16 Apr, 2020
- Jurisdiction Lucknow, Uttar Pradesh, India
- Annual Revenue₹92.9 Lakh
FY 2021
- Net Profit₹3.3 Lakh
FY 2021 · 4% margin
- EBITDA₹24.9 Lakh
FY 2021 · 27% margin
- Employee Count1
Associated legal entities of Ledgent Pharma
Ledgent Pharma operates through Ledgent Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2021) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ledgent Pharma Private Limited CIN U51909UP2020PTC128282 | Active | 16 Apr 2020 | Lucknow, Uttar Pradesh | ₹0.9 Cr | 2 | View details |
Board of directors of Ledgent Pharma Private Limited (Ledgent Pharma)
Ledgent Pharma Private Limited is the primary company behind Ledgent Pharma. The board of Ledgent Pharma Private Limited currently have 2 directors; the longest-serving is Kamlesh Kumar Yadav, appointed in 2020.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kamlesh Kumar Yadav DIN 08734984 | Director | 16 Apr 2020 | 6 yrs 7 mo | Ledgent Pharma Private Limited |
| Udbhav Kumar Tripathi DIN 08734985 | Director | 16 Apr 2020 | 6 yrs 7 mo | Ledgent Pharma Private Limited |
Financials of Ledgent Pharma
Figures of Ledgent Pharma Private Limited, the primary company behind Ledgent Pharma, for FY 2021. Revenue was ₹92.9 Lakh. Net profit was ₹3.3 Lakh (4% margin). EBITDA was ₹24.9 Lakh (27% margin).
- ₹92.9 LakhRevenue · FY 2021
- ₹3.3 LakhNet profit · 4% margin
- ₹24.9 LakhEBITDA · 27% margin
- ₹1 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Ledgent Pharma Private Limited are on its company page.
Detailed financial statements for Ledgent Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Ledgent Pharma
Ledgent Pharma has 3 listed similar companies in our database, 1 of them funded. They include Indoco Remedies, Concord Biotech and BDR Pharmaceuticals Internationals.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| indoco.com | 1947 | Mumbai, India | 6,291 | APIs manufacturing and formulation services are provided in therapeutic segments. | ||
| concordbiotech.com | 2000 | Ahmedabad, India | 1,598 | APIs and enzymes are manufactured through fermentation by the CDMO. | ||
| bdrpharma.com | 2003 | Mumbai, India | $88.16M | 1,864 | APIs and finished products are developed and manufactured. |
Detailed similar companies of Ledgent Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Ledgent Pharma
Ledgent Pharma was founded in 2020.
Ledgent Pharma is headquartered in Kanpur, India. It is registered at Kanpur, Uttar Pradesh, India.
Ledgent Pharma has 1 employees.
The primary company behind Ledgent Pharma, Ledgent Pharma Private Limited, reported revenue of βΉ92.9 Lakh for FY 2021.
Ledgent Pharma operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and developing products. Produces high-quality pharmaceutical products for the healthcare industry. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Ledgent Pharma's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Indoco Remedies.
Ledgent Pharma operates through Ledgent Pharma Private Limited.
The legal entities of Ledgent Pharma currently have 2 directors, including Kamlesh Kumar Yadav, Udbhav Kumar Tripathi.